Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting.

Autor: Gencheva, R., Petrova, M., Kraleva, P., Hadjidekova, S., Radanova, M., Conev, N., Stoyanov, D., Arabadjiev, J., Tazimova, E., Bachurska, S., Eneva, M., Tsvetkova, M., Zhbantov, G., Karanikolova, T., Manov, D., Ivanova, A., Taushanova‐Hadjieva, M., Staneva, R., Dimitrova, E., Donev, I.
Zdroj: Cancer Reports; Feb2024, Vol. 7 Issue 2, p1-8, 8p
Databáze: Complementary Index
Externí odkaz: